95
Empowering the Pharmacist with Telepharmacy Mitch Larson

Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Empowering the Pharmacist with Telepharmacy

Mitch Larson

Page 2: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Disclosures

Cardinal Health has a commercial interest in telepharmacy, but does not reference any commercial products in this presentation.

The opinions and recommendations expressed by the presenter are their own, and are to be used for educational purposes only.

Page 3: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Learning objectives

1. Explain why telepharmacy started and how it has

evolved with technology.

2. List the different types of telepharmacy and how its

use is improving patient care.

3. Describe the telepharmacy regulatory environment

around the United States and what states are doing

with rules.

Page 4: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Agenda

1. State of the industry and importance of innovation

2. Telepharmacy overview and history

3. The need for telepharmacy

4. Use cases and benefits of telepharmacy - pharmacists

5. Regulatory landscape and advocacy

Page 5: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

1. State of the Industry & Importance of Innovation

Page 6: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Do you feel pressures facing the pharmacy industry today?

Page 7: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Are there opportunities ahead of the pharmacy industry today?

Page 8: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Industry pressures

Mail order pharmacies

Physician dispensing

Reimbursement fees

Increased competition

Patient non-adherence

Industry opportunities

Technological advancements

Patient-centered care

Demand from MUA’s

Proven safety and efficiency of

existing technologies

State of the pharmacy industry today

Page 9: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Innovation adoption lifecycle

Page 10: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

$

Electronic billing

Technicians in the

pharmacy

Automatic ordering

Automated dispensing

Advances increase safety & efficiency

Page 11: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Unit dose drug distribution

35 years 35 years

IV Admixture programs

Pharmacist on patient care

team

40 years

25 years

Pharmacy computerization

15 years

Automated dispensing

Data from ASHP National Survey

30 yr. average

Pharmacy’s history of slow adoption

Page 12: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Risk of not innovating

Page 13: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

❖ Struggling profitability

❖ Limited time for clinical activity

❖ Non-adherence rates

❖ Massive costs of non-adherence

What problems do pharmacist encounter today?

Page 14: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Source: https://www.ncpanet.org/home/ncpa-digest

2.1%

3.1%3.3%

Average Net Operating Income

Pharmacies struggle with profitability

Page 15: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

How much of your time is spent on clinical activities?

Page 16: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Source: 2016, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043635/

40.3%Value added tasks represent

Only 40.3%of pharmacist’s time

(Clinical and patient interactions)

Limited time for clinical activities

Page 17: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

50% 25%

Treatment failures

Hospitalizations

Medication non-adherence can account for:

Adherence to chronic medications is about

50%

Source: 2018, https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-room

Page 18: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

$100 billionMedication non-adherence alone results in

each year in excess hospitalizations.

Source: 2018, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045499/

$290 billionAnnually in mostly avoidable costs to treat

adverse events from inappropriate medication use

Opportunity to improve non-adherence costs

Page 19: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Pharmacies & Pharmacists are best positioned to address these problems

STOP

Page 20: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

❖ Increase revenue by providing

more value to more patients

❖ Allow pharmacists to practice at

the top of their license

❖ Reduce or better optimize costs

❖ Implement innovative practices

into our business

We should be finding ways to:

Page 21: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Immunizations Telepharmacy Pharmacogenomic testing

Direct to consumer Point of care testing Medication therapy management

Current trends address industry opportunities

Page 22: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Immunizations Telepharmacy Pharmacogenomic testing

Direct to consumer Point of care testing Medication therapy management

Current trends address industry opportunities

Page 23: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

2. Telepharmacy Overview and History

Page 24: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

There are four types of telepharmacy

INPATIENT OUTPATIENT

Remote order entry review

IV admixture

Retail telepharmacy

Remote counseling

Page 25: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

There are four types of telepharmacy

INPATIENT OUTPATIENT

Remote order entry review

IV admixture

Retail telepharmacy

Remote counseling

Page 26: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Australia’s Royal Flying Doctor Service

1942

Page 27: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

1942

2001

2002

2006

Australia’s Royal Flying Doctor Service

North Dakota: first US state to allow

Community Health Assoc. in Spokane, WA

NDSU study

US Navy begins telepharmacy

Telepharmacy historical timeline

Page 28: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

In what year did the iPad first come out?

A. 2003B. 2006C. 2010

Page 29: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

In what year did the iPad first come out?

A. 2003B. 2006C. 2010

Page 30: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

North Dakota study proves safety

Source: The North Dakota Experience: Achieving High-Performance Health Care Through Rural Innovation And Cooperation. May 2008

Information of the

North Dakota

Telepharmacy Program

provided by North

Dakota State University

School of Pharmacy

81telepharmacies

Medication dispensing error rate for

telepharmacies

<1.3%Compared to a national

average of: ~1.7%

Study conducted from2002 - 2008

Result: Positive outcomes, mechanisms could be improved

Page 31: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

North Dakota telepharmacy case study

Source: The North Dakota Experience: Achieving High-Performance Health Care Through Rural Innovation And Cooperation. May 2008

Information of the

North Dakota

Telepharmacy Program

provided by North

Dakota State University

School of Pharmacy

Page 32: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

What does a retail telepharmacy look like?

A. A brick and mortar location staffed by one or more pharmacy technicians.

B. An online portal where patients pay for medications and have them shipped.

C. A pharmacist-shaped robot.

Page 33: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

What does a retail telepharmacy look like?

A. A brick and mortar location staffed by one or more pharmacy technicians.

B. An online portal where patients pay for medications and have them shipped.

C. A pharmacist-shaped robot.

Page 34: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

● A brick-and-mortar location,

just like any other pharmacy

● A pharmacist is not on-site

● Pharmacists verify prescriptions

for the telepharmacy through

either a live video feed or

images

● Pharmacists counsel patients

via a live video call

A telepharmacy is:

Page 35: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

New prescription arrives at Pharmacy A1

Technician A fills, taking images of the process2

Pharmacist B reviews images to verify fill is accurate

3

Patient picks up Rx at Pharmacy A and Pharmacist B counsels

4Tec

h

B

RPh Tec

h

Telepharmacy workflow

Rx

A

Telepharmacy Host Pharmacy

Page 36: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

The telepharmacy feelslike a traditional pharmacy

The Patient’s Perspective

Page 37: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

❖ Greeted by technician

❖ Pharmacist is always

available

The Patient’s Perspective

Page 38: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

The prescriptions are filled and verified

Technician fills

prescription, taking images

of the process

Prescription is remotely

verified by a pharmacist

via HIPAA-compliant

software

2

1

The Patient’s Perspective

Page 39: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Additional services while they wait

❖ OTC products

❖ Immunizations when

pharmacist is on site

❖ Consult pharmacist with

any questions

The Patient’s Perspective

Page 40: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Consult with the

pharmacist

❖ Visit with your pharmacist via

secure two-way audio-visual

software

❖ Your pharmacist is presented

with your patient notes

during the call

The Patient’s Perspective

Page 41: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Patient leaves with

medications in hand

and questions

answered

The Patient’s Perspective

Done!

Page 42: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

3. The Need for Telepharmacy

Page 43: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

In what setting do you think telepharmacy is most needed?

A. Rural areas

B. Urban areas

C. Both

Page 44: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

In what setting do you think telepharmacy is most needed?

A. Rural areas

B. Urban areas

C. Both

Page 45: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Need for alternative delivery

independent rural pharmacies closed

1,231

Source: Update: Independently Owned Pharmacy Closures in Rural America, 2003-2018; RUPRI Center for Rural Health Policy Analysis, Rural Policy Brief July 2018; Abiodun Salako, MPH; Fred Ullrich, BA; Keith J. Mueller, PhD

630rural communities

lost their only pharmacy

Independent Rural Pharmacies 2003-2018

7,624

6,393

12.1%

decrease

2007-2009

7.2%decrease

16.1%decrease

Page 46: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Rural access is declining

64+ millionIndependent pharmacies

closed between 2003-2018. People in the US

living in rural areas

1.7+ millionResidents living in rural

pharmacy deserts 10+ miles from the nearest pharmacy

1,231

Source: Update: Independently Owned Pharmacy Closures in Rural America, 2003-2018; RUPRI Center for Rural Health Policy Analysis, Rural Policy Brief July 2018; Abiodun Salako, MPH; Fred Ullrich, BA; Keith J. Mueller, PhD

Page 47: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

How many pharmacy deserts does New Hampshire have?

A. 18

B. 32

C. 6

Page 48: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

How many pharmacy deserts does New Hampshire have?

A. 18

B. 32

C. 6

Page 49: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

New Hampshire Pharmacy Deserts

Map of pharmacy deserts in NH

10 mile radius around Manchester

Page 50: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

A study in Oregon found that readmission rates were

higher in rural areas than urban, but both are still high:

Rural readmission rates higher than urban

15.3%

Source: Lack of pharmacy access sends some patients back to the hospital; Oregon State University and Oregon Health & Science University, August 2016

Rural

14.7%

Urban

Page 51: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Rural is becoming more rural

Source: One in Five Americans Live In Rural Areas; What is rural America? America Counts Staff; August 9, 2017. Available at:https://www.census.gov/library/stories/2017/08/rural-america.htmlHealth Professional Shortage Areas, 2017 postcard. National Conference of State Legislatures; August 30, 2017; Available at: https://www.ncsl.org/research/health/health-professional-shortage-areas-2017-postcard.aspx

59%Of Primary Care Health Provider

Shortage Areas are located in rural settings

64 Million(1 in 5)

People in the US livein rural areas

Page 52: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Need for improved access in urban areas

32% or 1 millionPeople in Chicago’s 802

census tracts were in urban pharmacy deserts

1+ milesDistance to the nearest pharmacy in an urban

pharmacy desert

Source: Qato, Daviglus, Wilder, Lee, Quato, Lambert. (2014). ‘Pharmacy deserts’ are prevalent in Chicago’s predominantly minority communities, raising medication access concerns. Health Affairs, 1958-1965. https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2013.1397

Closure riskIncreased in urban pharmacies

serving more low-income, uninsured, or publicly insured

Page 53: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

“The Leaky Bucket” of Medication Adherence

Source: IMS Health Data, March 2011

Out of every 100 new

prescriptions

50-70 arrive at a pharmacy

48-66are picked upby the patient

25-30are takenproperly

15-20 are refilled as prescribed

According to IMS Health:

Page 54: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

The “ultimate cost” of non-adherence

50% 25%

Treatment failures Hospitalizations

Deaths

125k

Avoidable Healthcare Costs

$290B

Page 55: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Frequent interactions with patients

Souce: Pharmacists Want More Time with Patients. March 18, 2019. Fred Gebhart, PharmD. Available at: https://www.drugtopics.com/article/pharmacists-want-more-time-patients

Patients visit their

pharmacist more than any

other healthcare provider

Provider # visits

Primary care physician 4

Other healthcare providers 9

Pharmacist 35

Page 56: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Better EducationBetter Access

Better Outcomes

+

Pharmacist important in patient care lifecycle

Page 57: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

4. Use Cases and Benefits for Pharmacists

Page 58: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Improve medication adherence rates

Expand access to new patient populations

Increase clinical interventions

Pharmacist’s opportunity with telepharmacy

Page 59: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Community telepharmacy increases patient access

Prescription Shop

Olton, Texas

❖ 4 years without a pharmacy

❖ 25 miles away from the nearest pharmacy

❖ Delivery to Olton was becoming expensive

❖ Telepharmacy location now in Olton

❖ Went from delivering 25-40 scripts per day to 60-70 scripts per day

Source: https://blog.telepharm.com/community-telepharmacy-in-texas-qa-with-micah-pratt-pharmacist

Page 60: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

UW Health

Madison, Wisconsin

Retail telepharmacy in a community health center

❖ Partnership with clinic

❖ Allows on-site pharmacy at low volume locations

❖ Ability to utilize pharmacists more effectively in the clinic

Source: https://www.telepharm.com/success-stories/madison-wi-health-system-provides-better-pharmacy-access-for-chc-patients/

Page 61: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Rural telepharmacy next to a health clinic

Page 62: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Interior of a rural telepharmacy

Page 63: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

In-clinic pharmacy providing 340B

● Physical drug inventory

● Certified technicians on site

● Small OTC

Page 64: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Telepharmacy in a FQHC

Page 65: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Rural telepharmacy revives Main Street

BEFORE

AFTER

Page 66: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

NORTH DAKOTAResults of the 6-year study with

81 locations:

ILLINOISEstimate for one pharmacy

based on financial data:

Economic benefits of telepharmacy

Source: North Dakota Telepharmacy Project https://www.ndsu.edu/telepharmacy/; Rural Economic Technical Assistance Center

(RETAC) in Macomb, IL; Economic impacts of a pharmacy for Deiterich, Illinois, June 2015

$26.5 millionin economic development

80-100new jobs created

$640,000annual economic impact

Page 67: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

● Free up time from dispensing tasks

● Ability to perform more clinical activities

○ MTM○ Immunizations○ Flu clinics○ Counseling sessions

Pharmacists practice at the top of their license

Page 68: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Elevated role for technicians

● Training & certification

● Under direct pharmacist supervision

● Perform more duties

● Get to be the “face” of the pharmacy

● Organize and schedule on-site visits

Page 69: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Pros/Cons of Hardware or AMDS solutions

Advantages

• Can be available 24 hours

• No on-site staff needed

Disadvantages

• Cost-prohibitive

• Limited formulary

• Mechanical failure

• Complicated

Page 70: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Pros/Cons of Software solutions

Advantages

• Live pharmacist interaction

• Constant updates

• Low initial costs

• Better education

• More opportunities

Disadvantages

• Can be limited hours

• Live internet connection

Page 71: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

New opportunities for pharmacy access

Workload balancing

Hospitals

Accessible specialists

Pharmacy deserts

Page 72: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

5. Regulatory Landscape and Advocacy

Page 73: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Telepharmacy regulations, 2008

Source: Telepharmacy project expands across country; 9/12/2008; Dave Kolpack, Associated Press

IA

IL

S

MN

ND

IN

MI

WISD

NE

KS MO

TX

OK

CA

WY

MT

ID

WA

OR

NM

CO

AZ

OHUT

NV

LA

AR

TN

ALMS

KY

WV

FL

GA

NY

SC

NC

VA

PA NJ

VTNH

MACT

AK

HI

MD

ME

DE

RI

Permitted, but practice may be restricted and/or requires Board approval

In progress

Not permitted

Page 74: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

How many states allow the practice of telepharmacy today?

A. 13

B. 51

C. 40

D.24

Page 75: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

How many states allow the practice of telepharmacy today?

A. 13

B. 51

C. 40

D.24

Page 76: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

IA

IL

S

MN

ND

IN

MI

WISD

NE

KS MO

TX

OK

CA

WY

MT

ID

WA

OR

NM

CO

AZ

OHUT

NV

LA

AR

TN

ALMS

KY

WV

FL

GA

NY

SC

NC

VA

PA NJ

VT

NH

MA

CT

AK

HI

MD

ME

DE

RI

Permitted, but practice may be restricted and/or requires Board approval

In progress

Not permitted

Telepharmacy regulations, 2020

Page 77: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Frequently asked questions

Fill accuracy

Safety

Diversion

Internet outages

?1

2

3

4

Page 78: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Regulations vary widely by state depending on:

• Practice setting

• Verification site location

• Urban allowances

• Many other factors

States that have telepharmacy language can benefit from aligning their rules

NABP created model telepharmacy language in 2017

Regulations are fragmented

Page 79: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Typical telepharmacy regulations

#Pharmacy technician

certification

hours/experience

Special rules around

controls Limits on number of

remote sites or

technicians

Security requirements Mileage restrictions Technology

requirements

Page 80: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

As you advocate for telepharmacy, remember

● The need is increasing every year○ Pharmacy closures, underserved areas

● Get ahead of the technology and legislators○ Make the rules for your industry, not outsiders

● Successful programs already in place○ There are plenty of good examples to look at and use

● Consider the future○ Think about the future, don’t be nearsighted (Blockbuster)

Page 81: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Steps to implementing regulations

3

2

1

4

5

Look for statutory authority

Board committee drafts rules

Board notices rules to public

Public comment period

Administrative rules review & approval

Implementation

Page 82: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Tips to drafting regulations

Look into what other states have for regulation

Visit a retail telepharmacy location which is in operation

Understand the landscape in your state

Ensure statutes leave room for administrative rules

Page 83: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #1

A.) Remote Order Entry

B.) Remote Dispensing

C.) Remote

Consultation

D.) Internet Pharmacy

Which of these is not a

type of “telepharmacy”?

Page 84: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #1

A.) Remote Order Entry

B.) Remote Dispensing

C.) Remote

Consultation

D.) Internet Pharmacy

Which of these is not a

type of “telepharmacy”?

Page 85: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #2

A.) True

B.) False

C.) Answering this

question is a slippery

slope

D.) I can neither

confirm or deny this

Telepharmacy is becoming

less prevalent in America.

Page 86: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #2

A.) True

B.) False

C.) Answering this

question is a slippery

slope

D.) I can neither

confirm or deny this

Telepharmacy is becoming

less prevalent in America.

Page 87: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #3

A.) Pharmacist

B.) Primary Care

Physician

C.) Dentist

D.) Veterinarian

Which of the following

healthcare providers has

the most patient contact?

Page 88: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #3

A.) Pharmacist

B.) Primary Care

Physician

C.) Dentist

D.) Veterinarian

Which of the following

healthcare providers has

the most patient contact?

Page 89: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #4

A.) Yes, it created over

80 new jobs

B.) Yes, but all the jobs

went to China

C.) No, no new jobs

were created

D.) No, it actually took

away jobs

Available data from the

implementation of

telepharmacy in North

Dakota showed the

creation of new jobs.

Page 90: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #4

A.) Yes, it created over

80 new jobs

B.) Yes, but all the jobs

went to China

C.) No, no new jobs

were created

D.) No, it actually took

away jobs

Available data from the

implementation of

telepharmacy in North

Dakota showed the

creation of new jobs.

Page 91: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #5

A.) Seniors

B.) Low vehicle

ownership

C.) Both

D.) Neither

Which group would be

considered to have access

issues?

Page 92: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #5

A.) Seniors

B.) Low vehicle

ownership

C.) Both

D.) Neither

Which group would be

considered to have access

issues?

Page 93: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #6

A.) Telepharmacy in warfarin clinics

B.) Telepharmacy to allow HIV medications at discharge

C.) Telepharmacy to allow overnight coverage at rural hospitals/clinics

D.) All of the above

Which of the following are

ways to increase

pharmacist presence?

Page 94: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

CE Question #6

A.) Telepharmacy in warfarin clinics

B.) Telepharmacy to allow HIV medications at discharge

C.) Telepharmacy to allow overnight coverage at rural hospitals/clinics

D.) All of the above

Which of the following are

ways to increase

pharmacist presence?

Page 95: Empowering the Pharmacist with Telepharmacy Presentations...3. Describe the telepharmacy regulatory environment around the United States and what states are doing with rules. Agenda

Questions?

Mitch [email protected]

For updates and more information, visit telepharm.com/learn